CO5251417A1 - Inhibidor de mataloproteasa acido aromatico sulfohidroxamico - Google Patents

Inhibidor de mataloproteasa acido aromatico sulfohidroxamico

Info

Publication number
CO5251417A1
CO5251417A1 CO00035030A CO00035030A CO5251417A1 CO 5251417 A1 CO5251417 A1 CO 5251417A1 CO 00035030 A CO00035030 A CO 00035030A CO 00035030 A CO00035030 A CO 00035030A CO 5251417 A1 CO5251417 A1 CO 5251417A1
Authority
CO
Colombia
Prior art keywords
mmp
aromatic
mataloprotease
sulfohydroxamic
acima
Prior art date
Application number
CO00035030A
Other languages
English (en)
Inventor
Thomas E Barta
Daniel P Becker
Louis J Bedell
Terri L Boehm
Jeffrey N Carroll
Gary A Decrescenzo
M Fobian Yvette
John N Freskos
Daniel P Getman
Joseph J Mcdonald
Susan L Hockerman
Susan C Howard
Stephen A Kolodziej
H Li Madeleine
Deborah A Mischke
Joseph G Rico
W Stehle Nathan
Michael B Tollefson
William F Vernier
Clara I Villamil
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of CO5251417A1 publication Critical patent/CO5251417A1/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Un proceso de tratamiento de un mamífero huésped que presenta una condición asociada con actividad patológica de la metaloproteasa matriz de una cantidad efectiva de un ácido sulfon-hidroxámico aromático que presenta una excelente actividad inhibitoria de una o más de las encimas de la metaloproteasa matriz (MMP), tales como MMP-2, MMP-9 y MMP-13, mientras que presenta una actividad inhibitoria sustancialmente menor al menos contra la MMP-1. <EMI FILE="00035030_1" ID="1" IMF=JPEG >
CO00035030A 1999-05-14 2000-05-15 Inhibidor de mataloproteasa acido aromatico sulfohidroxamico CO5251417A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31183799A 1999-05-14 1999-05-14

Publications (1)

Publication Number Publication Date
CO5251417A1 true CO5251417A1 (es) 2003-02-28

Family

ID=27757522

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00035030A CO5251417A1 (es) 1999-05-14 2000-05-15 Inhibidor de mataloproteasa acido aromatico sulfohidroxamico

Country Status (5)

Country Link
AR (1) AR035547A1 (es)
CO (1) CO5251417A1 (es)
PE (1) PE20010202A1 (es)
UY (1) UY26145A1 (es)
ZA (1) ZA200109006B (es)

Also Published As

Publication number Publication date
UY26145A1 (es) 2000-12-29
ZA200109006B (en) 2002-12-02
PE20010202A1 (es) 2001-02-19
AR035547A1 (es) 2004-06-16

Similar Documents

Publication Publication Date Title
ATE287885T1 (de) Hydroxamsäure-sulfonamid-derivate mit amidiertem aromatischen ring
TR200103493T2 (tr) Metaloproteaz önleyicileri
JO2283B1 (en) Pyrimidinyl-N-Acyl-L-Phenyl Anines
BR9811099A (pt) Inibidores de urocinase
ATE254599T1 (de) Divalente sulfonyl-aryl-oder heteroaryl hydroxamsäureverbindungen
AP2001002240A0 (en) Sufamato hydroxamic acid metalloprotease inhibitor.
NO983688L (no) Serin-protease-inhibitorer
EP0931788A3 (en) Metalloprotease inhibitors
AU8647101A (en) Compounds having activity as inhibitors of cytochrome p450rai
NO20013675L (no) 2,3,4,5-tetrahydro-1H-[1,4)benzodiazepin-3-hydroksamsyre som matriks-metalloproteinase-inhibitorer
NZ515197A (en) Hydroxamic acid derivatives useful as matrix metalloprotease inhibitors
CA2266759A1 (en) 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
NO20003828L (no) 2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepin-3-hydroksamsyrer som matriks-metalloproteinase inhibitorer
CO5251417A1 (es) Inhibidor de mataloproteasa acido aromatico sulfohidroxamico
NZ516620A (en) 1,4-substituted 4,4-diaryl cyclohexanes
DK1244643T3 (da) Tryptaseinhibitorer
WO2001082911A3 (en) TREATMENT OF PATHOLOGICAL CONDITIONS INFLUENCED BY THE ACTION OF MATRIX METALLOPROTEINASES (MMPs) USING CLIOQUINOL
DK1244614T3 (da) Tryptase-inhibitorer
DE69332904T2 (de) Hemmung von hiv-infektion
ZA974032B (en) Substituted oxobutyric acids as matrix metalloproteinases inhibitors.
CA2262582A1 (en) Hcg and derivatives as matrix metalloproteases inhibitors
AR016514A1 (es) Composicion para mejorar el malestar estomacal, metodo para preparar dicha composicion y metodo para utilizarla
FR2784582B3 (fr) Nouvelle utilisation therapeutique de composes a activite beta-3-agoniste
TH62357A (th) สารยับยั้งเมทัลโลโปรตีเอสของกรดอะโรมาติกซัลโฟนไฮดรอกซามิค
MY141460A (en) Aromatic sulfone hydroxamic acid metalloprotease inhibitor

Legal Events

Date Code Title Description
FC Application refused